Dohyun Nam is the founder of AIMEDBIO. AIMEDBIO has raised $67M in total funding. Latest round: Growth. Based in Seoul, South Korea.
Dohyun Nam is the Co-Founder and CEO of AimedBio Inc., a Seoul-based biotechnology company founded in 2018. He leads the company's efforts in developing antibody-drug conjugate (ADC) therapeutics for brain diseases, focusing on blood-brain barrier penetration and brain immune modulation.
Full founder directory · Investor directory · Company funding database · Fundraising library